Featured Lectures will include:
|Professor Lawrie Beilin, MB, BS, MD, FRACP, FRCP, FCSANZ|
Emeritus Professor Lawrie Beilin was a Winthrop Professor of Medicine with the School of Medicine & Pharmacology at the Royal Perth Hospital Campus for the University of Western Australia and Consultant Physician at Royal Perth Hospital from 1977 to 2011. He continues work in an Honorary Senior Research Fellow appointment and has Emeritus Professor title with the University of Western Australia and is an Emeritus Physician at Royal Perth Hospital. He has been the Chair of the Royal Perth Hospital Medical Research Foundation since 2000. He has had a distinguished academic and scientific research career engaged in research into high blood pressure over the last 48 years beginning in London and Oxford and since 1977 he has developed a research team in the University of Western Australia Cardiovascular Research Centre which has been responsible for major advances in understanding the role of diet, and lifestyle in high blood pressure and cardiovascular disease. His current focus is on the developmental origins of cardiometabolic disorders studying the West Australian Childhood Cohort. He has over 600 publications and his contributions to knowledge in his area of research have been recognised Nationally and Internationally by incorporation of his group’s work in Heart Foundation Guidelines, World Health Organisation and International Society of Hypertension Guidelines. For his contributions to medical education and research he was awarded the Prime Ministers Centenary Medal in 2001 and the Officer of the Order of Australia in the General Division (AO) in 2003 as well as other National teaching and research awards. Professor Beilin has held many positions on National and International Committees over the above period and was President of the International Society of Hypertension from 2002 to 2004 and was Vice President of the World Hypertension Leaque from 2008-2012. In 2010 he was awarded the Stevo Julius Award of the International Society of Hypertension for contributions to community research and education in Hypertension.
|Jeremiah Stamler, MD|
Jeremiah Stamler, MD, received his undergraduate degree from Columbia University in New York in 1940 and MD degree from the State University of New York in 1943. Dr. Stamler has been on the faculty of Northwestern's Feinberg School of Medicine since 1958. He served as Chair of the Department of Preventive Medicine until 1986, and as Professor until 1990, when he became Emeritus Professor.
Throughout his career, his research concerns have been the causation and prevention of the major adult cardiovascular diseases (CVD), particularly coronary heart disease (CHD). In previous work, as extensively reported in the literature, Dr. Stamler served in leadership capacities in numerous Chicago, national, and international intervention studies -- e.g., the Chicago Coronary Prevention Evaluation Program, the Coronary Drug Project, the National Diet-Heart Study, the Hypertension Detection and Follow-up Program, the Multiple Risk Factor Intervention Trial, the Hypertension Control Program, the trial on the Primary Prevention of Hypertension, trials on aspirin and dipyridamole, the Systolic Hypertension in the Elderly trial, the DASH trial on effects of dietary patterns on blood pressure, the AFCAPS/TexCAPS trial on coronary prevention with lovastatin.
Dr. Stamler's work in population-based research began in the 1950s, and continues to the present. It has involved several long-term studies, all extensively reported (See Dr. Stamler’s CV) - - e.g., 16 cohorts worldwide studied jointly by the International Collaborative Group; 4 cohorts in China under long-term study by the PRC-USA Collaborative Study on Cardiovascular and Cardiopulmonary Epidemiology; the INTERSALT Study on effects on blood pressure of dietary sodium, potassium, alcohol, protein, and other factors, as assessed in 52 adult population samples in 32 countries worldwide; the INTERMAP Study on macro-/micronutrients and blood pressure, involving 17 population samples of men and women ages 40-59 in China, Japan, the U.K., and the U.S.
Throughout his career Dr. Stamler has been a participant in the activities of the American Heart Association (AHA) and its Chicago Affiliate. He also has been active for years at the international level, as Chair of the Council on Epidemiology and Prevention of the International Society and Federation of Cardiology (ISFC), then as Chair of the ISFC Scientific Board. He has served as an Editor and Editorial Board member of major journals in his areas of expertise (e.g., Atherosclerosis, Circulation, Hypertension, Journal of Chronic Diseases, Journal of Human Hypertension, Preventive Medicine). He has also served on numerous expert panels and advisory groups on public policy for prevention and control of CHD-CVD, at the national and international level, e.g., for the AHA; the ISFC; the National Heart, Lung, and Blood Institute, National Institutes of Health; the World Health Organization.
|L. Adrienne Cupples, PhD|
|L. Adrienne Cupples, Ph.D. is Professor of Biostatistics (former Chair) and of Epidemiology. She has a long standing interest in statistical methods for epidemiologic studies, for survival data analysis and for genetic epidemiology/statistical genetics. She has taught and mentored students for thirty years at Boston University School of Public Health, and has received the Norman A Scotch Award for Excellence in Teaching (1995) and the Faculty Career Award in Research & Scholarship (2010). She was Visiting Professor at the University of Leeds, UK (2006) and at the National University of Singapore (2007). She received a NIH/NIGMS NRSA Senior Fellowship (1988-89), the Janet L. Norwood Award for Outstanding Achievement by a Woman in the Statistical Sciences (2010) and the L. Adrienne Cupples Award (2012). She has collaborated in the Framingham Heart Study for 30 years on a variety of topics from risk factors for sudden death, nutritional epidemiology and most recently the genetic etiology of cardiovascular disease and its risk factors, especially glycemic traits, lipids and adiposity. She is Co-Principal Investigator of the Framingham Heart Study and a member of the Framingham Genetics Steering Committee. She is actively involved in the Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) Consortium, especially in the development and implementation of statistical methods for genome-wide association studies and sequencing studies, and in the Genetic Investigation of Anthropomorphic Traits (GIANT) Consortium. She also has a long history studying the genetic etiology of Huntington disease and of Alzheimer’s disease, particularly in genetic risk prediction and evaluation of how people interpret and respond to such predictions.|
|William E. Kraus, MD|
|Dr. Bill Kraus, is a Professor of Medicine in the Division of Cardiovascular Medicine and the Duke Institute of Molecular Physiology. He is a clinician scientist with research interests in the use of exercise for favorable mediation of cardiometabolic risk; in the role of skeletal muscle adaptations in mediating that risk; and in the study of how we can use a better understanding of gene-environment interactions to focus preventive measures in cardiovascular medicine. Dr. Kraus' clinical focus is in the areas of cardiovascular prevention with a focus on lifestyle modification, and in cardiac rehabilitation. He has been the Medical Director of Cardiac Rehabilitation at Duke since 1994 and served as the Director of Duke's Center for Living, an outpatient lifestyle prevention center, from 1996 to 1999. He currently runs a cardiovascular prevention clinic that is focused on combining lifestyle and medical interventions to address issues associated with cardiometabolic risk. He is the author of over 250 peer reviewed publications and 200 abstracts.|
|Martin Gibala, PhD|
Dr. Martin Gibala is a professor and Chair of the Department of Kinesiology at McMaster University in Hamilton, Canada. He studies the regulation of energy metabolism at the molecular to whole body level in both healthy and diseased states. Dr. Gibala also conducts applied research that examines the impact of nutrition and training on exercise performance. His work on physiological adaptations to high-intensity interval training has generated intense interest in both scientific and athletic circles as well as from international media. This research has been funded by numerous agencies including the Canadian federal granting councils NSERC and CIHR as well as the Canadian Diabetes Association. Dr. Gibala has served as an invited consultant to several leading sports agencies and was a co-author of the most recent consensus statement on sports nutrition for The International Olympic Committee. In 2005 he received the SIRC Award for Outstanding High Performance Sport Research in Canada. Dr. Gibala has also received three awards for teaching excellence from McMaster University as well as a President’s Award for Excellence in Graduate Student Supervision.
|Jonathan M. Samet, MD, MS|
|Jonathan M. Samet, M.D., M.S. is Professor and Flora L. Thornton Chair of the Department of Preventive Medicine at the Keck School of Medicine of the University of Southern California (USC), and Director of the USC Institute for Global Health. Dr. Samet received a Bachelor’s degree in Chemistry and Physics from Harvard College, an M.D. degree from the University of Rochester, School of Medicine and Dentistry, and a Master of Science degree in Epidemiology from the Harvard School of Public Health. He is trained in the specialty of internal medicine and in the subspecialty of pulmonary diseases. Dr. Samet’s research has addressed active and passive smoking and the effects of inhaled pollutants in the general environment, both indoors and outdoors, and in the workplace. Dr. Samet has served as Editor and Author for Reports of the Surgeon General on Smoking and Health since 1984, receiving the Surgeon General’s Medallion in 1990 and 2006 for these contributions. He is the Senior Scientific Editor for the 50th Anniversary 2014 report. He has received the Prince Mahidol Award for Global Health, the Alton Ochsner Award Relating Smoking and Health, the WHO World No Tobacco Day Award, the Doll-Wynder Award from SRNT, and the Edward Livingston Trudeau Medal from the American Thoracic Society/American Lung Association. He currently serves as chair of the Tobacco Products Scientific Advisory Committee (TPSAC) for the Food and Drug Administration. Dr. Samet was elected to the Institute of Medicine (IOM) in 1997.|
|James O. Hill, PhD|
|James O. Hill, Ph.D. is the Founding Executive Director of the Anschutz Health and Wellness Center at the University of Colorado. He is the Anschutz Professor of Pediatrics, Medicine and Physiology & Biophysics. He holds a Ph.D. degrees from the University of New Hampshire in Physiological Psychology. He was Chair of the first World Health Organization Consultation on Obesity in 1997. He was President of The Obesity Society (TOS) 1997-8 and The American Society for Nutrition (ASN) 2008-9. He was a member of the NIH Expert Panel on Obesity that developed first U.S guidelines for the treatment and prevention of obesity. Dr. Hill has published more than 500 scientific articles and book chapters, most focused on weight management. He is the recipient of the 2007 TOPS award and the 2012 George Bray Founders Award from TOS. He has received the Centrum Center, McCollum and Kritchevsky awards from the ASN. He is the 2012 Atwater Lecturer for the US Department of Agriculture. Dr. Hill is a cofounder of the National Weight Control Registry, a registry of individuals who have been successful in maintenance of a reduced body weight. He is co-founder of America on the Move, a national weight gain prevention initiative that aims to inspire Americans to make small changes in how much they eat and how much they move to prevent weight gain. He is the author of the Step Diet Book, published in June 2004 and the State of Slim published in August 2013.|
|Michelle Albert, MD, MPH, FACC|
A graduate of Haverford College, University of Rochester School of Medicine and Harvard School of Public Health, Dr. Albert completed her residency and chief residency in Internal Medicine at Columbia University in New York and Cardiovascular Fellowship at the Brigham and Women’s Hospital/Harvard Medical School in Boston, MA, where she was an Associate Professor in Medicine and Director of Behavioral and Neurocardiovascular Cardiology. Recently, Dr. Albert transitioned to Howard University, Washington DC where she is the Vivian Beaumont Allen Endowed Chair and Professor of Medicine. She is the Chief of Cardiovascular Medicine and Director of Cardiovascular Research. Dr. Albert is also an Adjunct Professor of Medicine at Johns Hopkins Medicine.
Dr. Albert has served as the Vice-President of the Association of Black Cardiologists, USA and served on their Board, has also served on the Young Clinician and Investigator and Acute Cardiac Care Committees of the American Heart Association and the Cardiovascular Training and Workforce Committee of the American College of Cardiology. She is the Chair of the AHA Executive Database Steering Committee and serves on the AHA Science Advisory and Coordination Committee as well as the AHA Executive Steering Committee of the 2012 Women's Triennial Health Tracking Study in CVD and Stroke. Dr. Albert recently served as a member of the National Academy of Sciences, Institute of Medicine Committee on Qualification of Biomarkers and Surrogate Endpoints in Chronic Disease. Dr. Albert has several mentees at all levels of training at the Brigham and Women's Hospital, Massachusetts General Hospital and Harvard Medical School along as well as at multiple other institutions across the United States. Due to the latter, Dr. Albert was nominated for the 2011-2012 Excellence in Mentoring Award by Harvard Medical School.
Dr. Albert’s research focuses on the molecular and genetic epidemiology of hemostasis, thrombosis and inflammation. A central component of this research involves understanding the biology of the interplay between chronic psychological stress and cardiovascular disease in vulnerable populations. Dr. Albert has received several research awards and including the Brigham and Women’s Hospital Minority Faculty Development Award, the Learner Cardiovascular Young Investigator Award, the Nikki Harris Family Cardiovascular Research Award, the Herbert Nickens Epidemiology Award from the Association of Black Cardiologists, received an award for best science in the 2007 AHA Scientific Sessions Poster Competition and the ACC 2012 Heart of Women's Health credo award. Dr. Albert’s research has been supported as principal investigator on grants from the Donald W. Reynolds Foundation, the Robert Wood Johnson Foundation, Kellogg Foundation and Doris Duke Foundation, a H. Robert Nesson Fellowship Award and RO1 funding from the National Institutes of Health.
|Sean P. David, MD, SM, Dphil|
|Dr. David is a physician scientist with training in family medicine, public health, and pharmacogenetics. He received his B.S. in Zoology and M.D. at the University of Washington, a Master of Science in Health and Social Behavior from the Harvard School of Public Health and a Ph.D. in Pharmacology from the University of Oxford. He is a Clinical Associate Professor of Family & Community Medicine at Stanford University School of Medicine. He was the inaugural James C. Puffer, M.D./American Board of Family Medicine/Institute of Medicine Fellow, a member of the Board of US BMJ Fellows and the Strategic Dialogue on Harm Reduction II and is on the Scientific Advisory Committee of the University of California Tobacco-Related Disease Research Program and SRITA (Stanford Research into The Impact of Tobacco Advertising) and works with the Stanford Prevention Research Center. His work focuses on translating genomic science into personalized treatments for smoking cessation and discovery of biomarkers to guide clinical and public health preventive strategies and, more broadly, on the integration of primary care, public health and science-based policy to advance the public health.|
|Martha Daviglus, MD, PhD|
|Dr. Daviglus is a Professor of Medicine, Director of the Institute for Minority Health Research, and Associate Vice Chancellor for Research at the University of Illinois at Chicago (UIC). She is also an Adjunct Professor of Preventive Medicine at Northwestern University Feinberg School of Medicine. Her research activities have concentrated on the epidemiology and prevention of cardiovascular diseases and minority health disparities, for which she has received numerous grants and awards including the Established Investigator Award from the American Heart Association. Dr. Daviglus has had continuous funding from the National Institutes of Health since 1995 and has been involved in investigating associations of traditional cardiovascular and nutritional risk factors with long-term coronary and cardiovascular morbidity (clinical and subclinical) and mortality in middle-aged and older men and women. Dr. Daviglus' other research interests focus on the benefits in older age, in terms of health care costs and health-related quality of life, of favorable (low risk) cardiovascular risk profile earlier in life, and on women's and Hispanic/Latino health. Dr. Daviglus is the principal investigator on a number of longitudinal studies including the Hispanic Community Health Study/ Study of Latinos (HCHS/SOL) Chicago Field Center, the Chicago Healthy Aging Study, and the UIC Cohort of Patients, Family, and Friends.|
|Cristina Rabadán-Diehl, PhD, MPH|
Dr. Cristina Rabadán-Diehl is an expert on cardiovascular health and serves as acting director of the Office of Global Health for the National Heart, Lung, and Blood Institute (NHLBI). She is also the Director of the NHLBI Global Health Initiative Program and the Scientific Manager for the NIH within the Global Alliance for Chronic Diseases (GACD).
Dr. Rabadán-Diehl has a degree in pharmacy from the Universidad Complutense of Madrid (Spain); a Ph.D. from the University of Miami (FL); and an M.P.H. and Health Communications Certificate from the Johns Hopkins University School of Public Health (Baltimore, MD).
Dr. Rabadán-Diehl is a member of several professional associations; served as an external advisor for the Canadian Institutes of Health Research Cardiovascular Complications of Diabetes Initiative; and an editorial board member for the World Journal of Diabetes and The Journal of Developmental Origins of Health and Disease.
Dr. Rabadán-Diehl joined the NIH in 1993 as a fellow in the Developmental Endocrinology Branch at the intramural program in the Eunice Kennedy Shriver National Institute of Child Health and Human Development. In 2002, she joined the NHLBI extramural program. Prior to joining the Office of Global Health in May 2010, Dr. Rabadán-Diehl served as a program director in the NHLBI Division of Cardiovascular Sciences (DCVS). She managed an extensive research portfolio of grants, contracts and cooperative agreements primarily in the areas of diabetes complications and developmental origins of adult disease. Her extensive expertise in atherosclerosis, hypertension, diabetes, endocrinology, preclinical models of disease and bio-behavioral stress led her to serve as the NHLBI representative in many multidisciplinary intra- and inter-NIH collaborative programs.
Dr. Rabadán-Diehl has helped develop multidisciplinary partnerships at the global level. She has enabled research teams and has bridged research endeavors among the basic, translational, clinical and population science communities, domestically and internationally.
|Stephan Gielen, MD, FESC|
Ass. Prof. Stephan Gielen works as Director of the Cardiac Catheterization Laboratory and Deputy Director of the Dept. of Internal Medicine III at the Martin-Luther-University Halle-Wittenberg, Halle, Germany. Before assuming his current position he completed his training in internal medicine, clinical cardiology, and interventional cardiology at the Heart Center Leipzig (University of Leipzig, Germany) 1997-2012, where he also started his scientific career in exercise physiology and pathophysiology of exercise intolerance in chronic heart failure. He is lead author of the Chapter on Cardiac Rehabilitation of the ESC Textbook of Cardiovascular Medicine and author/coauthor of more than 60 peer-reviewed scientific articles.
In the EACPR he has contributed as Chair-elect of the Section on Exercise Physiology, Treasurer (2008-10), President-elect (2010-12) before becoming the current EACPR President 2012-14. His focus for the EACPR is on expanding international cooperation in implementing cardiovascular disease prevention and on the production of the ESC Textbook of Preventive Cardiology.
|Ian M. Graham, FRCPI, FESC, FTCD|
Ian Graham is Professor of Cardiovascular Medicine in Trinity College, Dublin, and Professor Emeritus of Preventive Cardiology at the Royal College of Surgeons in Ireland. He is Chairman of the Adelaide Hospital Society and of its Health Policy Initiative. He is a member of the 5th Joint European Societies Task Force on the Prevention of Cardiovascular Disease in clinical practice and of its Prevention Implementation Committee, having Chaired the 4th Task Force. He will co-Chair the 2016 European Guidelines on the management of dyslipidaemias.
Prof Graham studied medicine at Trinity College in Dublin, and worked in Dublin and Cambridge before becoming Head of Cardiology at Tallaght Hospital in Dublin and Vice-Chair of its Board of management. He was Director of Research at St Vincent’s Hospital and at the Irish Heart Foundation. He is past President of the Irish Heart Foundation, the Dublin University Biological Association and the Irish Hyperlipidaemia Association. He founded the Irish National Cardiac Surgery register.
He is an honorary Fellow of Trinity College in Dublin, and recipient of the Stokes Medal of the Irish Cardiac Society, and the Sir Thomas and Lady Dixon Medal from the Royal Victoria Hospital in Belfast. He held a Medical Research Council Fellowship, an EU travelling Fellowship at Erasmus University in Rotterdam and an ISFC Cardiovascular Epidemiology Fellowship.
Prof Graham is Project leader of the EU Concerted Action Project SCORE (Systematic COronary Risk Evaluation) and of its electronic derivative, HeartScore. He is a member of the EuroAspire risk factor audit, and Project Leader of a simplified international audit, SURF (Survey of Risk Factors).
|Shanthi Mendis, MBBS, MD, FRCP, FACC|
|Dr Shanthi Mendis is currently Senior Adviser, Noncommunicable Diseases in the noncommunicable diseases and mental health cluster at the World Health Organization (WHO). Since joining the World Health Organization (WHO) 15 years ago she has functioned as Director and Coordinator in Chronic Disease Prevention and Management and Senior Adviser, Cardiovascular Diseases. She is a Public Health Specialist and a Specialist in Internal Medicine and Cardiology and a Fellow of the Royal College of Physicians and the American College of Cardiology. She was Professor of Medicine, at the Faculty of Medicine, Sri Lanka for 10 years before being recruited to WHO. She graduated in Medicine from the University of Sri Lanka with first Class Honours in 1974 and did her internship in Bristol, UK and practiced medicine in England, Scotland and USA. She obtained her postgraduate qualifications from the UK and post-doctoral training in research and cardiology in USA. She has wide experience in global public health, all aspects of prevention and control of noncommunicable diseases, internal medicine and operational research.|